Literature DB >> 10824596

In vitro fluorescence, toxicity and phototoxicity induced by delta-aminolevulinic acid (ALA) or ALA-esters.

S Eléouet1, N Rousset, J Carré, L Bourré, V Vonarx, Y Lajat, G M Beijersbergen van Henegouwen, T Patrice.   

Abstract

Synthesis of delta-aminolevulinic acid (ALA) derivatives is a promising way to improve the therapeutic properties of ALA, particularly cell uptake or homogeneity of protoporphyrin IX (PpIX) synthesis. The fluorescence emission kinetics and phototoxic properties of ALA-n-pentyl ester (E1) and R,S-ALA-2-(hydroxymethyl) tetrahydrofuranyl ester (E2) were compared with those of ALA and assessed on C6 glioma cells. ALA (100 micrograms/mL), E1 and E2 (10 micrograms/mL) induced similar PpIX-fluorescence kinetics (maximum between 5 and 7 h incubation), fluorescence being limited to the cytoplasm. The 50% lethal dose occurred after 6 h with 45, 4 and 8 micrograms/mL of ALA, E1 and E2, respectively. ALA, E1 and E2 induced no dark toxicity when drugs were removed after 5 min of incubation. However, light (25 J/cm2) applied 6 h after 5 min incubation with 168 micrograms/mL of each compound induced 85% survival with ALA, 27% with E1 and 41% with E2. Increasing the incubation time with ALA, E1 and E2 before washing increased the phototoxicity, but E1 and E2 remained more efficient than ALA, regardless of incubation time. ALA-esters were more efficient than ALA in inducing phototoxicity after short incubation times, probably through an increase of the amount of PpIX synthesized by C6 cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10824596     DOI: 10.1562/0031-8655(2000)071<0447:ivftap>2.0.co;2

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  7 in total

1.  Nanoscopic micelle delivery improves the photophysical properties and efficacy of photodynamic therapy of protoporphyrin IX.

Authors:  Huiying Ding; Baran D Sumer; Chase W Kessinger; Ying Dong; Gang Huang; David A Boothman; Jinming Gao
Journal:  J Control Release       Date:  2011-01-10       Impact factor: 9.776

2.  Acute morphological sequelae of photodynamic therapy with 5-aminolevulinic acid in the C6 spheroid model.

Authors:  Pitr Zelenkov; Reinhold Baumgartner; Karl Bise; Michael Heide; Richard Meier; Susanne Stocker; Ronald Sroka; Roland Goldbrunner; Walter Stummer
Journal:  J Neurooncol       Date:  2006-09-27       Impact factor: 4.130

3.  5-aminolevulinic acid ester-induced protoporphyrin IX in a murine melanoma cell line.

Authors:  Flavia C B Vena; Rozane F Turchiello; Isabelle Laville; Sophie Pigaglio; Jocelyne Blais; Antonio C Tedesco
Journal:  Lasers Med Sci       Date:  2004       Impact factor: 3.161

4.  Protoporphyrin IX distribution following local application of 5-aminolevulinic acid and its esterified derivatives in the tissue layers of the normal rat colon.

Authors:  E Endlicher; P Rümmele; F Hausmann; R Krieg; R Knüchel; H C Rath; J Schölmerich; H Messmann
Journal:  Br J Cancer       Date:  2001-11-16       Impact factor: 7.640

5.  Protoporphyrin IX enhancement by 5-aminolaevulinic acid peptide derivatives and the effect of RNA silencing on intracellular metabolism.

Authors:  L Bourré; F Giuntini; I M Eggleston; M Wilson; A J MacRobert
Journal:  Br J Cancer       Date:  2009-02-24       Impact factor: 7.640

6.  Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies.

Authors:  C Perotti; H Fukuda; G DiVenosa; A J MacRobert; A Batlle; A Casas
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

7.  Derivatives of 5-aminolevulinic Acid for photodynamic therapy.

Authors:  Ryan F Donnelly; Paul A McCarron; A David Woolfson
Journal:  Perspect Medicin Chem       Date:  2007-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.